tiprankstipranks
Coya expands pipeline for COYA 302, adding Alzheimer’s Disease
PremiumThe FlyCoya expands pipeline for COYA 302, adding Alzheimer’s Disease
3M ago
Coya  expands patent estate beyond COYA 302 for inflamation reduction
PremiumThe Fly
Coya expands patent estate beyond COYA 302 for inflamation reduction
3M ago
Coya Therapeutics to host conference call
PremiumThe Fly
Coya Therapeutics to host conference call
3M ago
Coya announces pre-IND meeting, Type C meeting with FDA for COYA 302
PremiumThe FlyCoya announces pre-IND meeting, Type C meeting with FDA for COYA 302
4M ago
Coya Therapeutics files to sell 4.69M shares of common stock for holders
PremiumThe Fly
Coya Therapeutics files to sell 4.69M shares of common stock for holders
4M ago
Coya Therapeutics’ CEO gives update, sufficient cash for COYA 302 Phase 2 trial
PremiumThe Fly
Coya Therapeutics’ CEO gives update, sufficient cash for COYA 302 Phase 2 trial
5M ago
Coya:Inflammation,oxidative stress may play role in severity/progression of ALS
PremiumThe FlyCoya:Inflammation,oxidative stress may play role in severity/progression of ALS
8M ago
Coya Therapeutics reports Q2 EPS (31c) vs ($1.32) last year
PremiumThe Fly
Coya Therapeutics reports Q2 EPS (31c) vs ($1.32) last year
9M ago
Coya data supports COYA 301 for Alzheimer’s, says Chardan
PremiumThe Fly
Coya data supports COYA 301 for Alzheimer’s, says Chardan
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100